Literature DB >> 24630733

Strong correlation between glycaemic variability and total glucose exposure in type 2 diabetes is limited to subjects with satisfactory glycaemic control.

S Suh1, J Y Joung2, S M Jin2, M Y Kim2, J C Bae2, H D Park3, M S Lee2, M K Lee2, J H Kim4.   

Abstract

AIMS: This study investigated the relationship between markers of overall glucose exposure, postprandial glucose excursions and glycaemic variability in patients with type 2 diabetes mellitus (T2DM).
METHODS: A total of 63 patients with T2DM (mean age 56 years) were enrolled. All wore a continuous glucose monitoring system (CGMS) device for 72 h to collect data on markers of overall glucose exposure, postprandial glucose excursions and glycaemic variability parameters.
RESULTS: Spearman's correlation analysis revealed significant correlations between all markers of overall glucose exposure and various parameters related to glucose excursions. The percent coefficient of variation (CV) showed the strongest correlation with glycated albumin (r=0.470, P<0.01). In participants with HbA1c levels < 7.5% (n=33), almost all glycaemic markers and glycaemic variability parameters were significantly correlated with each other. Also, all postprandial glucose excursion parameters showed significant correlation with other glycaemic markers, and all markers of overall glucose exposure were significantly related to mean glucose, postprandial glucose excursions and glycaemic variability parameters (except CV). In contrast, in participants with HbA1c levels ≥ 7.5% (n=30), no parameters of postprandial glucose excursions and glycaemic variability were related to any markers of chronic glycaemia.
CONCLUSION: Postprandial glucose excursions may explain glycaemic variability and total glucose exposures in well-controlled T2DM patients.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  1,5-Anhydroglucitol; Continuous glucose monitoring systems; Fructosamine; Glycated albumin; HbA(1c)

Mesh:

Substances:

Year:  2014        PMID: 24630733     DOI: 10.1016/j.diabet.2014.01.006

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  9 in total

Review 1.  Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy.

Authors:  L Monnier; C Colette; S Dejager; D R Owens
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

2.  Microbial Community Distribution and Core Microbiome in Successive Wound Grades of Individuals with Diabetic Foot Ulcers.

Authors:  Apoorva Jnana; Vigneshwaran Muthuraman; Vinay Koshy Varghese; Sanjiban Chakrabarty; Thokur Sreepathy Murali; Lingadakai Ramachandra; Kallya Rajgopal Shenoy; Gabriel Sunil Rodrigues; Seetharam Shiva Prasad; Dhananjaya Dendukuri; Andreas Morschhauser; Joerg Nestler; Harald Peter; Frank F Bier; Kapaettu Satyamoorthy
Journal:  Appl Environ Microbiol       Date:  2020-03-02       Impact factor: 4.792

Review 3.  Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

Authors:  Christina M Parrinello; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 4.  The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea.

Authors:  Seungjoon Oh; Suk Chon; Kyu Jeong Ahn; In-Kyung Jeong; Byung-Joon Kim; Jun Goo Kang
Journal:  Diabetes Metab J       Date:  2015-06       Impact factor: 5.376

5.  Morning Spot Urine Glucose-to-Creatinine Ratios Predict Overnight Urinary Glucose Excretion in Patients With Type 2 Diabetes.

Authors:  So Ra Kim; Yong Ho Lee; Sang Guk Lee; Sun Hee Lee; Eun Seok Kang; Bong Soo Cha; Hyun Chul Lee; Jeong Ho Kim; Byung Wan Lee
Journal:  Ann Lab Med       Date:  2017-01       Impact factor: 3.464

6.  Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus.

Authors:  Kei Nakata; Takayuki Miki; Masaya Tanno; Hirofumi Ohnishi; Toshiyuki Yano; Atsuko Muranaka; Tatsuya Sato; Hiroto Oshima; Yuki Tatekoshi; Masashi Mizuno; Koki Abe; Tetsuji Miura
Journal:  PLoS One       Date:  2017-12-19       Impact factor: 3.240

Review 7.  Glycemic Variability: How Do We Measure It and Why Is It Important?

Authors:  Sunghwan Suh; Jae Hyeon Kim
Journal:  Diabetes Metab J       Date:  2015-08       Impact factor: 5.376

8.  Effect of DPP-IV Inhibitors on Glycemic Variability in Patients with T2DM: A Systematic Review and Meta-Analysis.

Authors:  Subin Lee; Heeyoung Lee; Yoonhye Kim; EunYoung Kim
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

Review 9.  CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review.

Authors:  Anne-Esther Breyton; Stéphanie Lambert-Porcheron; Martine Laville; Sophie Vinoy; Julie-Anne Nazare
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-09       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.